Diabetes Care Devices - Japan | Statista Market Forecast

Revenue in the Diabetes Care Devices market market in Japan is anticipated to reach US$1.23bn in 2024.
The revenue is forecasted to exhibit an annual growth rate (CAGR 2024-2029) of 11.92%, which will lead to a market volume of US$2.15bn by 2029.
In a global context, the highest revenue will be generated the United States, amounting to US$11.71bn in 2024.
Japan is witnessing a significant shift towards advanced diabetes care devices, driven by an aging population and increased focus on personalized healthcare solutions.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Japan is witnessing considerable growth, fueled by factors such as advancements in technology, increasing prevalence of diabetes, and heightened consumer awareness about effective management solutions for better health outcomes.

Customer preferences: In Japan, there is a notable shift towards integrated diabetes management solutions that combine technology with user-friendly interfaces. Consumers are increasingly favoring devices that offer real-time data sharing with healthcare providers, reflecting a cultural emphasis on community and support in health management. Additionally, the aging population is driving demand for easy-to-use products, while younger demographics are drawn to smart technology, such as apps and wearables, that gamify diabetes management, emphasizing lifestyle integration and proactive health engagement.

Trends in the market: In Japan, the Diabetes Care Devices Market is experiencing a surge in the adoption of connected devices that enhance patient engagement and streamline management. There is a strong focus on user-friendly designs that cater to the needs of both elderly patients and tech-savvy younger individuals. The integration of mobile applications and wearables is becoming increasingly popular, allowing for seamless data sharing with healthcare professionals. This trend signifies a shift towards personalized care and proactive health management, emphasizing the importance of community support and patient empowerment, which may reshape industry strategies and product development.

Local special circumstances: In Japan, the Diabetes Care Devices Market is uniquely shaped by the aging population and a cultural emphasis on preventative health measures. The country’s advanced technological infrastructure supports the integration of sophisticated devices, while regulatory frameworks ensure high safety and efficacy standards. Additionally, the strong societal focus on community and family involvement in healthcare encourages the adoption of user-friendly technologies that facilitate shared management of diabetes. This blend of local culture and regulatory environment fosters a distinct market dynamic, promoting innovation and accessibility in diabetes care.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Japan is significantly influenced by macroeconomic factors such as demographic shifts, healthcare spending, and technological investments. The aging population drives demand for innovative diabetes management solutions, while Japan’s robust healthcare system, supported by government fiscal policies, ensures continuous funding for medical technologies. Additionally, global supply chain dynamics and trade agreements affect the availability and pricing of diabetes devices. As the Japanese government prioritizes preventive healthcare, investments in research and development foster innovation, enhancing the market’s capacity to meet the growing needs of diabetes patients.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.